Table 4.
Self-reported leisure-time physical activity (LTPA) by categories of BMI, sex, race/ethnicity, age, fitness, diabetes treatment, and cardiovascular disease history.
Variable | Categories | Energy Expenditure (kcal/wk) Median (25th, 75th Percentiles) N | Sweat Episodes per Week Median (25th, 75th Percentiles) N |
---|---|---|---|
BMI | 25.0 to <27.0 kg/m2 | 686.0 (224.0, 1515) N=46 | 1.0 (0.0, 3.0) N=46 |
27.0 to <30.0 kg/m2 | 644.0 (168.0, 1500) N=235 | 1.0 (0.0, 4.0) N=234 | |
30.0 to <35.0 kg/m2 | 640.5 (168.0, 1417) N=716 | 1.0 (0.0, 3.0) N=714 | |
35.0 to <40.0 kg/m2 | 514.8 (112.0, 1064) N=616 | 1.0 (0.0, 3.0) N=615 | |
≥40 kg/m2 | 280.0 (56.0, 784.0) N=522 | 0.0 (0.0, 2.5) N=520 | |
p-value | <.0001 | <.0001 | |
Sex | Men | 672.0 (196.0, 1490) N=911 | 1.0 (0.0, 3.0) N=907 |
Women | 392.0 (100.0, 944.0) N=1225 | 0.0 (0.0, 3.0) N=1223 | |
p-value | <.0001 | <.0001 | |
Race/Ethnicity | African American/Black | 392.0 (100.0, 840.0) N=401 | 0.0 (0.0, 3.0) N=400 |
White | 532.0 (140.0, 1316) N=1554 | 1.0 (0.0, 3.0) N=1550 | |
Hispanic | 392.0 (84.0, 1316) N=107 | 1.0 (0.0, 3.0) N=106 | |
Other/Mixed/Missing | 640.5 (112.0, 1200) N=74 | 0.0 (0.0, 3.0) N=74 | |
p-value | 0.0004 | 0.0919 | |
Age | <50 years | 524.0 (112.0, 1008) N=207 | 1.0 (0.0, 3.0) N=207 |
50 to <60 years | 504.0 (140.0, 1224) N=960 | 1.0 (0.0, 3.0) N=958 | |
60 to <70 years | 468.0 (112.0, 1200) N=807 | 1.0 (0.0, 3.0) N=803 | |
≥70 years | 528.5 (112.0, 1359) N=162 | 0.0 (0.0, 3.0) N=162 | |
p-value | 0.7388 | 0.6926 | |
Fitness | <6 METs | 226.0 (56.0, 747.5) N=644 | 0.0 (0.0, 2.0) N=642 |
6 to <9 METs | 505.5 (140.0, 1064) N=875 | 1.0 (0.0, 3.0) N=874 | |
8 to <10 METs | 728.0 (196.0, 1515) N=435 | 1.0 (0.0, 3.0) N=433 | |
≥10 METs | 1310 (560.0, 2263) N=180 | 3.0 (0.0, 4.0) N=179 | |
p-value | <.0001 | <.0001 | |
Diabetes Medication | No Glucose Lowering Medication | 616.0 (168.0, 1304) N=267 | 1.0 (0.0, 4.0) N=267 |
Glucose Lowering Medication (Not including insulin or thiazolidinedione) | 476.0 (112.0, 1205) N=964 | 1.0 (0.0, 3.0) N=960 | |
Thiazolidinedione | 449.0 (112.0, 1132) N=478 | 1.0 (0.0, 3.0) N=478 | |
Insulin Alone | 434.5 (140.0, 1008) N=86 | 1.0 (0.0, 3.0) N=86 | |
Insulin plus glucose lowering medication (Not including thiazolidinedione) | 426.0 (112.0, 1023) N=152 | 1.0 (0.0, 3.0) N=150 | |
Insulin plus thiazolidinedione | 561.0 (112.0, 1393) N=156 | 0.0 (0.0, 3.0) N=156 | |
p-value | 0.1434 | 0.3277 | |
Cardiovascular Disease History | No | 477.0 (112.0, 1182) N=1808 | 1.0 (0.0, 3.0) N=1804 |
Yes | 479.0 (112.0, 1344) N=328 | 1.0 (0.0, 3.0) N=326 | |
p-value | 0.9086 | 0.1849 |